136 related articles for article (PubMed ID: 8388821)
21. Pyrimidine-rich region mutations compensate for a stem-loop V lesion in the 5' noncoding region of poliovirus genomic RNA.
Stewart SR; Semler BL
Virology; 1999 Nov; 264(2):385-97. PubMed ID: 10562500
[TBL] [Abstract][Full Text] [Related]
22. Virology. Active poliovirus baked from scratch.
Couzin J
Science; 2002 Jul; 297(5579):174-5. PubMed ID: 12114601
[No Abstract] [Full Text] [Related]
23. Genetic stability of Sabin 1 strain of poliovirus: implications for quality control of oral poliovirus vaccine.
Rezapkin GV; Alexander W; Dragunsky E; Parker M; Pomeroy K; Asher DM; Chumakov KM
Virology; 1998 Jun; 245(2):183-7. PubMed ID: 9636357
[TBL] [Abstract][Full Text] [Related]
24. Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template.
Cello J; Paul AV; Wimmer E
Science; 2002 Aug; 297(5583):1016-8. PubMed ID: 12114528
[TBL] [Abstract][Full Text] [Related]
25. Live-attenuated strains of improved genetic stability.
Macadam AJ; Ferguson G; Stone DM; Meredith J; Almond JW; Minor PD
Dev Biol (Basel); 2001; 105():179-87. PubMed ID: 11763326
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic and genomic analysis of serotype 3 Sabin poliovirus vaccine produced in MRC-5 cell substrate.
Alirezaie B; Taqavian M; Aghaiypour K; Esna-Ashari F; Shafyi A
J Med Virol; 2011 May; 83(5):897-903. PubMed ID: 21412797
[TBL] [Abstract][Full Text] [Related]
27. Circulating type 1 vaccine-derived poliovirus may evolve under the pressure of adenosine deaminases acting on RNA.
Liu Y; Ma T; Liu J; Zhao X; Cheng Z; Guo H; Xu R; Wang S
J Matern Fetal Neonatal Med; 2015; 28(17):2096-9. PubMed ID: 25330844
[TBL] [Abstract][Full Text] [Related]
28. Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses.
Crowder S; Kirkegaard K
Nat Genet; 2005 Jul; 37(7):701-9. PubMed ID: 15965477
[TBL] [Abstract][Full Text] [Related]
29. [Genetic variability of Poliovirus: typing of strains isolated in Madagascar by restriction fragment length polymorphism (RFLP) assay].
Razafindratsimandresy R; Rakoto Andrianarivelo M; Rousset D
Arch Inst Pasteur Madagascar; 2003; 69(1-2):27-32. PubMed ID: 15678812
[TBL] [Abstract][Full Text] [Related]
30. Functional and genetic plasticities of the poliovirus genome: quasi-infectious RNAs modified in the 5'-untranslated region yield a variety of pseudorevertants.
Gmyl AP; Pilipenko EV; Maslova SV; Belov GA; Agol VI
J Virol; 1993 Oct; 67(10):6309-16. PubMed ID: 8396686
[TBL] [Abstract][Full Text] [Related]
31. Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472----U.
Svitkin YV; Cammack N; Minor PD; Almond JW
Virology; 1990 Mar; 175(1):103-9. PubMed ID: 2155504
[TBL] [Abstract][Full Text] [Related]
32. [Primary structure of the crossover region in the genome of two intertype poliovirus recombinant].
Romanova LI; Viktorova EG; Tol'skaia EA; Kolesnikova MS; Guseva EA
Bioorg Khim; 1985 Dec; 11(12):1685-7. PubMed ID: 3002394
[TBL] [Abstract][Full Text] [Related]
33. [Genetic determinants of neurovirulence and attenuation of poliovirus].
Azol VI
Mol Gen Mikrobiol Virusol; 1988 Jan; (1):3-9. PubMed ID: 2833691
[TBL] [Abstract][Full Text] [Related]
34. Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine.
Pollard SR; Dunn G; Cammack N; Minor PD; Almond JW
J Virol; 1989 Nov; 63(11):4949-51. PubMed ID: 2552175
[TBL] [Abstract][Full Text] [Related]
35. Strong inclination toward transition mutation in nucleotide substitutions by poliovirus replicase.
Kuge S; Kawamura N; Nomoto A
J Mol Biol; 1989 May; 207(1):175-82. PubMed ID: 2544735
[TBL] [Abstract][Full Text] [Related]
36. Recombinant polioviruses as candidate strains of oral poliovaccines.
Nomoto A
Dev Biol Stand; 1995; 84():123-7. PubMed ID: 7796944
[No Abstract] [Full Text] [Related]
37. Infectious cDNA, cell receptors and transgenic mice in the study of Sabin's poliovirus vaccines.
Racaniello VR
Biologicals; 1993 Dec; 21(4):365-9. PubMed ID: 8024752
[TBL] [Abstract][Full Text] [Related]
38. The 5' noncoding region and virulence of poliovirus vaccine strains.
Macadam AJ; Stone DM; Almond JW; Minor PD
Trends Microbiol; 1994 Nov; 2(11):449-54. PubMed ID: 7866703
[TBL] [Abstract][Full Text] [Related]
39. Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication.
Kuge S; Nomoto A
J Virol; 1987 May; 61(5):1478-87. PubMed ID: 3033275
[TBL] [Abstract][Full Text] [Related]
40. RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence.
Chumakov KM; Norwood LP; Parker ML; Dragunsky EM; Ran YX; Levenbook IS
J Virol; 1992 Feb; 66(2):966-70. PubMed ID: 1309923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
